Cell line · CVCL_1624
Papers33
1 to 20 of 33
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A PTX3/TLR4 axis sustains sonic hedgehog-medulloblastoma growth and defines a new therapeutic vulnerability. | Neuro Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 7,7"-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Detection of structural DNA variants in medulloblastomas using optical genome mapping. | Acta Neuropathol Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses. | J Biomed Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The dual HDAC/PI3K inhibitor CUDC-907 inhibits the growth and proliferation of MYC-driven Group 3 medulloblastoma. | Cell Death Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | Mol Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells. | J Neurooncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma. | EBioMedicine | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance. | FASEB Bioadv | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma. | Cell Rep | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines. | Cytotechnology | 2019 | Cellosaurus cites it | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma. | Mol Cancer Res | 2019 | Its Methods give the RRID and name the line | PubMed | |
| Jak2-mediated phosphorylation of Atoh1 is critical for medulloblastoma growth. | Elife | 2017 | Its Methods give the RRID and name the line | PubMed | |
| Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines. | Data Brief | 2016 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1624/papers